US Drug Recall Register

FDA Drug Recalls

11,815 recalls · Class II, newest first

Class II · Moderate risk Terminated

MethylPREDNISolone

Reason Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

US Compounding Inc NDC 62295-3115-07 D-0265-2016
Class II · Moderate risk Terminated

Methylcobalamin

Reason Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

US Compounding Inc NDC 62295-3251-04 D-0264-2016
Class II · Moderate risk Terminated

MedroxyPROGESTERone/Lidocaine

Reason Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

US Compounding Inc NDC 62295-3113-07 D-0263-2016
Class II · Moderate risk Terminated

Lincomycin/Lidocaine

Reason Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

US Compounding Inc NDC 62295-3104-07 D-0262-2016
Class II · Moderate risk Terminated

Lidocaine 1% PF

Reason Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

US Compounding Inc NDC 62295-3099-07 D-0261-2016
Class II · Moderate risk Terminated

L-Cysteine PF

Reason Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

US Compounding Inc NDC 62295-3239-01 D-0260-2016
Class II · Moderate risk Terminated

Choline chloride 50 mg/mL

Reason Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

US Compounding Inc NDC 62295-3294-06 D-0259-2016
Class II · Moderate risk Terminated

Hyaluronidase PF

Reason Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

US Compounding Inc NDC 62295-3239-01 D-0258-2016
Class II · Moderate risk Terminated

Hyaluronic Acid/Lidocaine

Reason Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

US Compounding Inc NDC 62295-3239-01 D-0257-2016
Class II · Moderate risk Terminated

Hyaluronic Acid/Lidocaine PF

Reason Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

US Compounding Inc NDC 62295-3249-03 D-0256-2016
Class II · Moderate risk Terminated

Hyaluronic Acid/Lidocaine PF

Reason Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

US Compounding Inc NDC 62295-3087-02 D-0255-2016
Class II · Moderate risk Terminated

Hcg/B12

Reason Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

US Compounding Inc NDC 62295-3083-99 D-0254-2016
Class II · Moderate risk Terminated

Glycopyrrolate USP

Reason Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

US Compounding Inc NDC 62295-3082-05 D-0253-2016
Class II · Moderate risk Terminated

Fentanyl PF 50 mL

Reason Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

US Compounding Inc NDC 62295-0002-50 D-0252-2016
Class II · Moderate risk Terminated

ePHEDrine Sulfate PF

Reason Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

US Compounding Inc NDC 62295-3084-07 D-0251-2016
Class II · Moderate risk Terminated

Dexamethasone Sodium Phosphate PF

Reason Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

US Compounding Inc NDC 62295-3227-02 D-0250-2016
Class II · Moderate risk Terminated

Dex Combo

Reason Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

US Compounding Inc NDC 62295-3057-06 D-0249-2016
Class II · Moderate risk Terminated

Dex LA 8

Reason Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

US Compounding Inc NDC 62295-3299-02 D-0248-2016
Class II · Moderate risk Terminated

Dapiprazole

Reason Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

US Compounding Inc NDC 62295-0201-99 D-0247-2016
Class II · Moderate risk Terminated

Cyclopent/PE/Tropic 2mL

Reason Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

US Compounding Inc NDC 62295-3299-02 D-0246-2016
Class II · Moderate risk Terminated

Cyclo/PE/Tropic/Ketor

Reason Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

US Compounding Inc NDC 62295-3044-07 D-0245-2016
Class II · Moderate risk Terminated

Cyclo/PE/Trop PF

Reason Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

US Compounding Inc NDC 62295-3049-03 D-0244-2016
Class II · Moderate risk Terminated

Brompheniramine Maleate

Reason Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

US Compounding Inc NDC 62295-3019-07 D-0243-2016
Class II · Moderate risk Terminated

Bi-Mix

Reason Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

US Compounding Inc NDC 62295-3254-05 D-0242-2016
Class II · Moderate risk Terminated

Betamethasone SP PF

Reason Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

US Compounding Inc NDC 62295-3016-02 D-0241-2016